OSPREY THERAPEUTICS

EUIPO EUIPO 2017 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark OSPREY THERAPEUTICS was filed as Word mark on 12/20/2017 at the European Union Intellectual Property Office.
It was registered as a trademark on 05/03/2018. The current status of the mark is "Trademark registered".

Trademark Details Last update: January 30, 2021

Trademark form Word mark
File reference 017624685
Application date December 20, 2017
Publication date January 25, 2018
Entry date May 3, 2018
Expiration date December 20, 2027

Trademark owner

2855 Gazelle Court
92010 Carlsbad,
US

Trademark representatives

Bischoffsheimlaan 15 1000 Brussels BE

goods and services

5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases and disorders; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and disorders; pharmaceutical preparations for the prevention and treatment of endocrinological diseases and disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases or disorders; pharmaceutical preparations for the prevention and treatment of liver diseases or disorders pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in gynecology and urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of genetic diseases and disorders; pharmaceutical preparations and human therapeutic preparations for treating and preventing amyloidosis, genetic diseases, disorders and conditions, and protein diseases, disorders and conditions; pharmaceutical preparations and human therapeutic preparations for treating neuropathy, neurological dysfunction, and damage to nerves, tissue, organs, intestinal tract, or bone marrow; injectable drugs for reducing production of transthyretin; antisense drugs

Trademark history

Date Document number Area Entry
January 7, 2021 Change Representative, Published
January 5, 2021 Change Representative, Published

ID: 11017624685